Scientific Advisory Council Composed of leaders in immunology and immuno-oncology, the Scientific Advisory Council guides the Cancer Research Institute’s research programs, deciding which promising scientific and medical research proposals will receive CRI funding and support. Director James P. Allison, PhD The University of Texas MD Anderson Cancer Center Associate Directors Nina Bhardwaj, MD, PhD Icahn School of Medicine at Mount Sinai Glenn Dranoff, MD Dana-Farber Cancer Institute Elizabeth M. Jaffee, MD Johns Hopkins University School of Medicine Carl F. Nathan, MD Weill Cornell Medicine Kunle Odunsi, MD, PhD The University of Chicago Ellen Puré, PhD University of Pennsylvania School of Veterinary Medicine Robert D. Schreiber, PhD Washington University School of Medicine E. John Wherry, PhD University of Pennsylvania School of Medicine Jedd D. Wolchok, MD, PhD Weill Cornell Medicine Members Frederick W. Alt, PhD Boston Children’s Hospital & Harvard Medical School Richard Axel, MD Columbia University Harvey Cantor, MD Dana-Farber Cancer Institute & Harvard Medical School Jonathan Cebon, PhD, FRACP Olivia Newton-John Cancer Research Institute Zhijian Chen, PhD University of Texas Southwestern Medical Center Max D. Cooper, MD Emory University Lisa M. Coussens, PhD Oregon Health and Science University Peter Cresswell, PhD Yale University Jason G. Cyster, PhD University of California, San Francisco Mark M. Davis, PhD Stanford University Charles G. Drake, MD, PhD NewYork-Presbyterian / Columbia University Medical Center and Johnson & Johnson Innovative Medicine Michael L. Dustin, PhD University of Oxford Kate A. Fitzgerald, PhD, MRIA University of Massachusetts Medical School Richard A. Flavell, PhD, FRS Yale University Thomas Gajewski, MD, PhD The University of Chicago Laurie H. Glimcher, MD Dana-Farber Cancer Institute Philip D. Greenberg, MD Fred Hutchinson Cancer Research Center & University of Washington Nir Hacohen, PhD Broad Institute of MIT and Harvard James R. Heath, PhD Institute for Systems Biology F. Stephen Hodi, MD Dana-Farber Cancer Institute Axel Hoos, MD, PhD Scorpion Therapeutics Patrick Hwu, MD Moffitt Cancer Center Darrell J. Irvine, PhD Massachusetts Institute of Technology Dirk Jaeger, MD National Center for Tumor Diseases Heidelberg Carl H. June, MD University of Pennsylvania School of Medicine Susan M. Kaech, PhD Salk Institute for Biological Studies Michael Kalos, PhD Next Pillar Consulting, LLC Michael Karin, PhD University of California, San Diego John M. Kirkwood, MD University of Pittsburgh School of Medicine Alexander Knuth, MD Hamad Medical Corporation Lewis L. Lanier, PhD University of California, San Francisco Christina S. Leslie, PhD Weill Cornell Medicine Hyam I. Levitsky, MD Century Therapeutics Ming O. Li, PhD Weill Cornell Medicine Dan R. Littman, MD, PhD New York University Medical Center Nils Lonberg, PhD Canaan Partners J. Christopher Love, PhD Massachusetts Institute of Technology Tak W. Mak, PhD, DSc, FRSC University Health Network Philippa C. Marrack, PhD National Jewish Health & University of Colorado Cornelis J.M. Melief, MD, PhD Leiden University Medical Center Ira Mellman, PhD Genentech, Inc. Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai Malcolm A.S. Moore, DPhil Memorial Sloan Kettering Cancer Center Lee Nadler, MD Harvard Medical School & Dana-Farber Cancer Institute Drew M. Pardoll, MD, PhD Johns Hopkins University School of Medicine Klaus Rajewsky, MD Max Delbrueck Center for Molecular Medicine Gwendalyn J. Randolph, PhD Washington University in St. Louis Anjana Rao, PhD La Jolla Institute for Immunology Antoni Ribas, MD, PhD University of California, Los Angeles Comprehensive Cancer Center Stanley R. Riddell, MD Fred Hutchinson Cancer Research Center & University of Washington Alexander Rudensky, PhD Memorial Sloan Kettering Cancer Center Bijan Safai, MD, DSc New York Medical College Shimon Sakaguchi, MD, PhD Osaka University Lawrence E. Samelson, MD National Cancer Institute, NIH Hans Schreiber, MD, DMSc, PhD The University of Chicago Ton N. Schumacher, PhD The Netherlands Cancer Institute & Leiden University Medical Center Padmanee Sharma, MD, PhD The University of Texas MD Anderson Cancer Center Craig L. Slingluff Jr., MD University of Virginia Health System Pramod K. Srivastava, MD, PhD University of Connecticut School of Medicine Susumu Tonegawa, PhD Massachusetts Institute of Technology Giorgio Trinchieri, MD National Cancer Institute, NIH Marcel van den Brink, MD, PhD City of Hope Los Angeles National Medical Center Ulrich H. von Andrian, MD, PhD Harvard Medical School Robert H. Vonderheide, MD, DPhil University of Pennsylvania Jennifer Wargo, MD The University of Texas MD Anderson Cancer Center Hao Wu, PhD Boston Children's Hospital & Harvard Medical School Kai W. Wucherpfennig, MD, PhD Dana-Farber Cancer Institute Cassian Yee, MD The University of Texas MD Anderson Cancer Center Rolf M. Zinkernagel, MD, PhD University of Zurich
Charles G. Drake, MD, PhD NewYork-Presbyterian / Columbia University Medical Center and Johnson & Johnson Innovative Medicine
